Skip to content
Congress·Reported·3 months ago

Congress orders HHS to review lung cancer research for women and underserved groups, and ways to expand screening

Also known as: Women and Lung Cancer Research and Preventive Services Act of 2025

Legislative Progress

Filed
Review
House
Senate
President

Impacts

Mixed Impacts(9)
Chronic Illness
Neutral
Medicare
Neutral
Medicaid
Neutral
Housing Assistance
Neutral
Aca Marketplace
Neutral
Military Active
Neutral
Military Veteran
Neutral
Veterans Benefits
Neutral
Child Tax Credit
Neutral

Key Points

  • Congress would direct the Health and Human Services Department to review what the federal government is doing on lung cancer research for women and underserved groups.
  • The review would also look at how to expand access to lung cancer preventive services, including screenings for people who meet national screening guidelines.
  • Health and Human Services would work with the Defense Department and the Veterans Affairs Department, aiming to spot gaps and speed up progress across agencies.
  • The bill calls for ideas on a national screening strategy and a national public education campaign focused on early detection.
  • Health and Human Services would have to send Congress a report with findings and recommendations within 2 years of the bill becoming law.
HealthcareVeteransCivil Rights

Milestones

4 milestones6 actions
Nov 18, 2025House

Placed on the Union Calendar, Calendar No. 332.

Nov 18, 2025House

Reported by the Committee on Energy and Commerce. H. Rept. 119-382.

Apr 29, 2025House

Ordered to be Reported by Voice Vote.

Apr 29, 2025House

Committee Consideration and Mark-up Session Held

Mar 25, 2025House

Referred to the House Committee on Energy and Commerce.

What Happens Next

Projected impacts based on AI analysis

Soon after the bill becomes law

Health and Human Services starts the interagency review with Defense and Veterans Affairs

Sets the work in motion to map research gaps and barriers to lung cancer screening for women and underserved groups; no immediate change to your insurance coverage yet.

During the review period after enactment

Agencies identify research gaps and opportunities (including environmental/genetic factors and better imaging)

Could shape what kinds of studies get prioritized next and what questions doctors can answer better over time, especially for women and underserved patients.

During the review period after enactment

Agencies develop recommendations for a national lung cancer screening strategy to expand access

May lead to future proposals like more screening locations, better referrals, and targeted outreach; any real change would require follow-up action and funding.

During the review period after enactment

Agencies develop recommendations for a national public education and awareness campaign

Could later mean more public messaging about symptoms and early detection, and more outreach to women and underserved communities.

Related News

5 articles

Source Information

Document Type

Congressional Bill

Official Title

Women and Lung Cancer Research and Preventive Services Act of 2025

Bill NumberHR 2319
Congress119th Congress
ChamberHouse of Representatives
Latest ActionPlaced on the Union Calendar, Calendar No. 332.

Sponsor

Cosponsors

(2)
R: 2

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.